Journal
DRUG DISCOVERY TODAY
Volume 26, Issue 7, Pages 1750-1758Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2021.03.022
Keywords
Cannabinoid receptor; Diabesity; Diabetes mellitus; Endocannabinoid; Obesity
Categories
Ask authors/readers for more resources
The review discusses the intricate relationship between obesity and diabetes, highlighting the involvement of endocannabinoid signaling system and CB1 receptor in regulating metabolism and adiposity. However, excessive activation of the EC system may result in severe consequences, such as depression and suicidal thoughts.
'Diabesity' refers to a rising epidemic indicated by the intricate relationship between obesity and diabetes. The global prevalence of these coexisting, insidious diseases increases social and economic health burdens at a rapid pace. Numerous reports delineate the involvement of the underlying endocannabinoid (EC) signaling system through the cannabinoid-1 (CB1) receptor in the regulation of metabolism and adiposity. Conversely, EC inverse agonists can result in severe depression and suicidal thoughts through interactions with CB1/2 receptors in the brain. This review attempts to elucidate a possible mechanism for the amelioration of diabesity. Moreover, we also highlight the available targets of the CB1 receptor, which could pave the way for safe and effective therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available